4//SEC Filing
Takimoto Chris H 4
Accession 0001209191-23-019421
CIK 0001496323other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 6:31 PM ET
Size
5.3 KB
Accession
0001209191-23-019421
Insider Transaction Report
Form 4
Takimoto Chris H
Chief Medical Officer
Transactions
- Sale
Common Stock
2023-03-14$18.73/sh−1,768$33,118→ 28,789 total
Footnotes (2)
- [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]This transaction was executed in multiple trades at prices ranging from $18.34 to $19.30. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Documents
Issuer
IGM Biosciences, Inc.
CIK 0001496323
Entity typeother
Related Parties
1- filerCIK 0001743780
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 6:31 PM ET
- Size
- 5.3 KB